Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Hisse Senetlerindeki Sıralama #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Hisse Fiyatı
$0.02765
Son senkronizasyon: 2024-12-23
Piyasa Değeri
$69.04K
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Histogen Inc. (HSTO)

Kategori

Histogen Inc. (HSTO) için EPS
September 2023 itibariyle EPS TTM: $-3.13
Histogen Inc. şirketinin en son finansal raporlarına ve hisse senedi fiyatına göre, şirketin mevcut EPS'si (TTM) $-3.13'dir. 2021 yılı sonunda, şirketin EPS'si $-7.51 idi; bu, 2020 yılındaki EPS olan $-41.60 ile önceki yıla göre artış.
Histogen Inc. için 2011 - 2026 arasındaki EPS geçmişi
Her yıl sonunda EPS
Yıl EPS Değiştir
2026 (TTM) $-3.13 -9.54%
2022 $-3.46 -53.93%
2021 $-7.51 -81.95%
2020 $-41.60 728.69%
2019 $-5.02 -95.77%
2018 $-118.60 -2.56%
2017 $-121.71 -53.64%
2016 $-262.55 20,096.15%
2015 $-1.30 -9.72%
2014 $-1.44 -32.08%
2013 $-2.12 -98.88%
2012 $-190.00 -26.92%
2011 $-260.00 0.00%
Benzer şirketler veya rakipler için EPS
Şirket EPS EPS Farkı Ülke
$17.32 -653.35%
US
$27.74 -986.26%
NL
- -
CH
- -
KR
$13.70 -537.70%
BE